Search research articles
Contact Us
Filters
Showing results (21-30 of 436) with videos related to
Page
of 44
Sort By:
Frontiers in Neuroscience
|
May 16, 2022
Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Deborah O T Alawode, Nick C Fox, Henrik Zetterberg, et al.
Cold Spring Harbor Perspectives in Medicine
|
April 5, 2012
Brain imaging in Alzheimer disease
Keith A Johnson, Nick C Fox, Reisa A Sperling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 18, 2013
An algorithmic approach to structural imaging in dementia
Lorna Harper, Frederik Barkhof, Philip Scheltens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Jemma Hazan, Kathy Y Liu, Robert Howard, et al.
Neurology
|
May 4, 2026
What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.
Frontiers in Neuroscience
|
April 1, 2022
Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities
Rebecca M C Gabriele, Emily Abel, Nick C Fox, et al.
The Lancet. Neurology
|
December 28, 2010
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele
Wiesje M van der Flier, Yolande Al Pijnenburg, Nick C Fox, et al.
Journal of Alzheimer'S Disease : JAD
|
January 25, 2012
Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial
David Wilkinson, Nick C Fox, Frederik Barkhof, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 8, 2006
Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations
Dominic C Paviour, Shona L Price, Marjan Jahanshahi, et al.
Nature Reviews. Neurology
|
February 9, 2010
The clinical use of structural MRI in Alzheimer disease
Giovanni B Frisoni, Nick C Fox, Clifford R Jack, et al.
Page
of 44
Search research articles
Search
Showing results (21-30 of 436) with videos related to
Sort By:
Page
of 44
Frontiers in Neuroscience
|
May 16, 2022
Alzheimer's Disease Biomarkers Revisited From the Amyloid Cascade Hypothesis Standpoint
Deborah O T Alawode, Nick C Fox, Henrik Zetterberg, et al.
Cold Spring Harbor Perspectives in Medicine
|
April 5, 2012
Brain imaging in Alzheimer disease
Keith A Johnson, Nick C Fox, Reisa A Sperling, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
October 18, 2013
An algorithmic approach to structural imaging in dementia
Lorna Harper, Frederik Barkhof, Philip Scheltens, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 25, 2025
Biomarkers
Jemma Hazan, Kathy Y Liu, Robert Howard, et al.
Neurology
|
May 4, 2026
What Does a Positive Alzheimer Disease Blood-Based Biomarker Result Mean in People With Mild Cognitive Impairment?
Jemma Hazan, Kathy Y Liu, Jeremy D Isaacs, et al.
Frontiers in Neuroscience
|
April 1, 2022
Knockdown of Amyloid Precursor Protein: Biological Consequences and Clinical Opportunities
Rebecca M C Gabriele, Emily Abel, Nick C Fox, et al.
The Lancet. Neurology
|
December 28, 2010
Early-onset versus late-onset Alzheimer's disease: the case of the missing APOE ɛ4 allele
Wiesje M van der Flier, Yolande Al Pijnenburg, Nick C Fox, et al.
Journal of Alzheimer'S Disease : JAD
|
January 25, 2012
Memantine and brain atrophy in Alzheimer's disease: a 1-year randomized controlled trial
David Wilkinson, Nick C Fox, Frederik Barkhof, et al.
Movement Disorders : Official Journal of the Movement Disorder Society
|
April 8, 2006
Regional brain volumes distinguish PSP, MSA-P, and PD: MRI-based clinico-radiological correlations
Dominic C Paviour, Shona L Price, Marjan Jahanshahi, et al.
Nature Reviews. Neurology
|
February 9, 2010
The clinical use of structural MRI in Alzheimer disease
Giovanni B Frisoni, Nick C Fox, Clifford R Jack, et al.
Page
of 44